111 related articles for article (PubMed ID: 25998519)
41. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
[TBL] [Abstract][Full Text] [Related]
42. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
Azuma K; Sasada T; Kawahara A; Takamori S; Hattori S; Ikeda J; Itoh K; Yamada A; Kage M; Kuwano M; Aizawa H
Lung Cancer; 2009 Jun; 64(3):326-33. PubMed ID: 18977553
[TBL] [Abstract][Full Text] [Related]
43. Prognostic value of ESR2 expression on adjuvant chemotherapy in completely resected NSCLC.
Yu H; Gu D; Qian P
PLoS One; 2020; 15(12):e0243891. PubMed ID: 33332474
[TBL] [Abstract][Full Text] [Related]
44. A comparison of machine learning methods for predicting recurrence and death after curative-intent radiotherapy for non-small cell lung cancer: Development and validation of multivariable clinical prediction models.
Hindocha S; Charlton TG; Linton-Reid K; Hunter B; Chan C; Ahmed M; Robinson EJ; Orton M; Ahmad S; McDonald F; Locke I; Power D; Blackledge M; Lee RW; Aboagye EO
EBioMedicine; 2022 Mar; 77():103911. PubMed ID: 35248997
[TBL] [Abstract][Full Text] [Related]
45. Drug repositioning for non-small cell lung cancer by using machine learning algorithms and topological graph theory.
Huang CH; Chang PM; Hsu CW; Huang CY; Ng KL
BMC Bioinformatics; 2016 Jan; 17 Suppl 1(Suppl 1):2. PubMed ID: 26817825
[TBL] [Abstract][Full Text] [Related]
46. Overall survival prediction of non-small cell lung cancer by integrating microarray and clinical data with deep learning.
Lai YH; Chen WN; Hsu TC; Lin C; Tsao Y; Wu S
Sci Rep; 2020 Mar; 10(1):4679. PubMed ID: 32170141
[TBL] [Abstract][Full Text] [Related]
47. Gene expression-based classification of non-small cell lung carcinomas and survival prediction.
Hou J; Aerts J; den Hamer B; van Ijcken W; den Bakker M; Riegman P; van der Leest C; van der Spek P; Foekens JA; Hoogsteden HC; Grosveld F; Philipsen S
PLoS One; 2010 Apr; 5(4):e10312. PubMed ID: 20421987
[TBL] [Abstract][Full Text] [Related]
48. DeepBTS: Prediction of Recurrence-free Survival of Non-small Cell Lung Cancer Using a Time-binned Deep Neural Network.
Lee B; Chun SH; Hong JH; Woo IS; Kim S; Jeong JW; Kim JJ; Lee HW; Na SJ; Beck KS; Gil B; Park S; An HJ; Ko YH
Sci Rep; 2020 Feb; 10(1):1952. PubMed ID: 32029785
[TBL] [Abstract][Full Text] [Related]
49. A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping.
Wen Q; Kim CS; Hamilton PW; Zhang SD
BMC Bioinformatics; 2016 May; 17(1):211. PubMed ID: 27170106
[TBL] [Abstract][Full Text] [Related]
50. Application of an artificial neural network for predicting the potential chemotherapy benefit of patients with gastric cancer after radical surgery.
Lu J; Xue Z; Xu BB; Wu D; Zheng HL; Xie JW; Wang JB; Lin JX; Chen QY; Li P; Huang CM; Zheng CH
Surgery; 2022 Apr; 171(4):955-965. PubMed ID: 34756492
[TBL] [Abstract][Full Text] [Related]
51. Network-based drug sensitivity prediction.
Ahmed KT; Park S; Jiang Q; Yeu Y; Hwang T; Zhang W
BMC Med Genomics; 2020 Dec; 13(Suppl 11):193. PubMed ID: 33371891
[TBL] [Abstract][Full Text] [Related]
52. Constructing a Risk Prediction Model for Lung Cancer Recurrence by Using Gene Function Clustering and Machine Learning.
Zhong J; Chen JM; Chen SL; Yi YF
Comb Chem High Throughput Screen; 2019; 22(4):266-275. PubMed ID: 30698110
[TBL] [Abstract][Full Text] [Related]
53. Machine Learning-Assisted Recurrence Prediction for Patients With Early-Stage Non-Small-Cell Lung Cancer.
Janik A; Torrente M; Costabello L; Calvo V; Walsh B; Camps C; Mohamed SK; Ortega AL; Nováček V; Massutí B; Minervini P; Campelo MRG; Del Barco E; Bosch-Barrera J; Menasalvas E; Timilsina M; Provencio M
JCO Clin Cancer Inform; 2023 Jul; 7():e2200062. PubMed ID: 37428988
[TBL] [Abstract][Full Text] [Related]
54. Novel gene signatures for stage classification of the squamous cell carcinoma of the lung.
Juarez-Flores A; Zamudio GS; José MV
Sci Rep; 2021 Mar; 11(1):4835. PubMed ID: 33649335
[TBL] [Abstract][Full Text] [Related]
55. Lung cancer prediction from microarray data by gene expression programming.
Azzawi H; Hou J; Xiang Y; Alanni R
IET Syst Biol; 2016 Oct; 10(5):168-178. PubMed ID: 27762231
[TBL] [Abstract][Full Text] [Related]
56. Accurate prediction of breast cancer survival through coherent voting networks with gene expression profiling.
Pellegrini M
Sci Rep; 2021 Jul; 11(1):14645. PubMed ID: 34282236
[TBL] [Abstract][Full Text] [Related]
57. Machine Learning techniques in breast cancer prognosis prediction: A primary evaluation.
Boeri C; Chiappa C; Galli F; De Berardinis V; Bardelli L; Carcano G; Rovera F
Cancer Med; 2020 May; 9(9):3234-3243. PubMed ID: 32154669
[TBL] [Abstract][Full Text] [Related]
58. Transfer learning with convolutional neural networks for cancer survival prediction using gene-expression data.
López-García G; Jerez JM; Franco L; Veredas FJ
PLoS One; 2020; 15(3):e0230536. PubMed ID: 32214348
[TBL] [Abstract][Full Text] [Related]
59. Prediction of Non-small Cell Lung Cancer Histology by a Deep Ensemble of Convolutional and Bidirectional Recurrent Neural Network.
Moitra D; Mandal RK
J Digit Imaging; 2020 Aug; 33(4):895-902. PubMed ID: 32333132
[TBL] [Abstract][Full Text] [Related]
60. Prediction of Lung Infection during Palliative Chemotherapy of Lung Cancer Based on Artificial Neural Network.
Guo W; Gao G; Dai J; Sun Q
Comput Math Methods Med; 2022; 2022():4312117. PubMed ID: 35047054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
